Ian McLeod
Comptroller/Controller/Auditor at ANIKA THERAPEUTICS, INC.
Ian McLeod active positions
Companies | Position | Start | End |
---|---|---|---|
ANIKA THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 30/06/2021 | - |
Career history of Ian McLeod
Former positions of Ian McLeod
Companies | Position | Start | End |
---|---|---|---|
IDENIX PHARMACEUTICALS INC | Comptroller/Controller/Auditor | 31/08/2004 | 31/10/2007 |
ABIOMED, INC. | Comptroller/Controller/Auditor | 31/10/2007 | - |
Training of Ian McLeod
McMaster University | Masters Business Admin |
University of Western Ontario | Undergraduate Degree |
Statistics
International
United States | 4 |
Canada | 3 |
Operational
Comptroller/Controller/Auditor | 3 |
Masters Business Admin | 1 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ANIKA THERAPEUTICS, INC. | Health Technology |
Private companies | 2 |
---|---|
ABIOMED, Inc.
ABIOMED, Inc. Medical SpecialtiesHealth Technology ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA. | Health Technology |
Idenix Pharmaceuticals LLC
Idenix Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Idenix Pharmaceuticals LLC is a biopharmaceutical company, which is engaged in the discovery and development of drugs for the treatment of human viral diseases with operations in the United States and France. Currently, its primary research and development focus is on the treatment of patients with hepatitis C virus, or HCV, using nucleotide polymerase inhibitors and NS5A inhibitors. Idenix Pharmaceuticals was founded by Jean-Pierre Sommadossi and Raymond F. Schinazi in May 1998 and is headquartered in Cambridge, MA. | Health Technology |
- Stock Market
- Insiders
- Ian McLeod
- Experience